{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:53:26Z","timestamp":1787014406871,"version":"build-2736575974"},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,2,16]],"date-time":"2004-02-16T00:00:00Z","timestamp":1076889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tissue Antigens"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    HLA allele mismatches will provoke T\u2010cell alloreactivity after allogeneic stem cell transplantation. As donors and recipients are usually HLA matched, the public HLA epitopes that are recognized by natural killer (NK) cells (NK epitopes) are rarely mismatched, and therefore there is rarely potential for NK alloreactivity arising from the absence of ligands for inhibitory killer immunoglobulin\u2010like receptors (\n                    <jats:italic>KIR<\/jats:italic>\n                    ). Transplants using related donors sharing only one haplotype (haploidentical donors) represent a setting in which NK epitopes are often mismatched, thus resulting in the potential for NK alloreactivity. We have analyzed engraftment, acute graft\n                    <jats:italic>vs<\/jats:italic>\n                    host disease (GVHD), leukemia relapse, and survival in 62 haploidentical transplants in relationship with potential NK alloreactivity, inhibitory, and activating\n                    <jats:italic>KIR<\/jats:italic>\n                    genes of class I HLA NK epitopes. Potential NK alloreactivity in the rejection direction was not associated with any outcome variable. Potential NK alloreactivity in the GVHD direction was associated with an increased incidence of severe GVHD and poorer patient survival but not with non\u2010engraftment nor leukemia relapse. A higher number of activating\n                    <jats:italic>KIR<\/jats:italic>\n                    receptors in the genome of the donor was associated with a higher prevalence of GVHD. These results suggest that lack of extensive T\u2010cell depletion in haploidentical transplantation is associated with high GVHD rates and diminishes the benefits of NK\u2010cell alloreactivity.\n                  <\/jats:p>","DOI":"10.1111\/j.0001-2815.2004.00182.x","type":"journal-article","created":{"date-parts":[[2004,2,16]],"date-time":"2004-02-16T06:03:35Z","timestamp":1076911415000},"page":"204-211","source":"Crossref","is-referenced-by-count":130,"title":["The beneficial role of inhibitory\n                    <i>KIR<\/i>\n                    genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor\u2010alloreactive T cells causing GVHD"],"prefix":"10.1111","volume":"63","author":[{"given":"A.","family":"Bishara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.C.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brautbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.T.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,2,16]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02090-0"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198106183042507"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198901263200401"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1997.tb00979.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(95)93061-G"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810223391702"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.1.333.413a31_333_339"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068440"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.134.6.1513"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1997.tb00981.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80051-9"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.359"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7716543"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.2.605"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.505"},{"key":"e_1_2_5_17_2","first-page":"1667","article-title":"The putative role of HLA\u2010C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation","volume":"23","author":"Bishara A","year":"1995","journal-title":"Exp Hematol"},{"key":"e_1_2_5_18_2","first-page":"510","article-title":"Killer inhibitory receptor (KIR) mismatches correlates with high incidence of transplant related complication post\u2010haploidentical stem cell transplantation (HaploSCT)","volume":"27","author":"Nagler A","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1197"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(02)00373-7"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02284-6"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/69.2.103"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1991.tb01891.x"},{"key":"e_1_2_5_24_2","first-page":"3349","article-title":"long toxicity following single dose total body irradiation in patients undergoing haploidentical stem cell transplantation","volume":"94","author":"Ben\u2010Yosef R","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702860"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03561.x"},{"key":"e_1_2_5_27_2","first-page":"43","article-title":"DNA typing for bone marrow engraftment follow\u2010up after allogeneic transplant: a comparative study of current technologies","volume":"16","author":"Leclair B","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_28_2","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80394-5"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-002-0476-2"},{"key":"e_1_2_5_31_2","first-page":"19","volume-title":"Statistical Methods for Research Workers","author":"Fisher RA","year":"1981"},{"key":"e_1_2_5_32_2","first-page":"121","volume-title":"Introduction to Statistical Analysis","author":"Dixon WJ","year":"1967"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non parametric estimation from incomplete observations","volume":"53","author":"Kaplan E","year":"1959","journal-title":"J Am Stat Assoc"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1268"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-002-0311-5"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(98)00026-5"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(96)80085-9"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0091"}],"container-title":["Tissue Antigens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-2815.2004.00182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0001-2815.2004.00182.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:02:10Z","timestamp":1697259730000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0001-2815.2004.00182.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,16]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1111\/j.0001-2815.2004.00182.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0001-2815.2004.00182.x","archive":["Portico"],"relation":{},"ISSN":["0001-2815","1399-0039"],"issn-type":[{"value":"0001-2815","type":"print"},{"value":"1399-0039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,16]]}}}